LAURIE PETERSON: Open Payments
NPI 1205898715 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,495 in 129 payments from 20 companies in 2025. Trend: 2023 $2,789 · 2024 $2,741 · 2025 $4,495
Food & beverage: $3,214Consulting: $1,215Travel & lodging: $66
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $1,635 |
| ABBVIE INC. | 32 | $655 |
| Janssen Biotech, Inc. | 16 | $350 |
| Ipsen Biopharmaceuticals, Inc | 9 | $315 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $292 |
| Gilead Sciences, Inc. | 12 | $275 |
| Phathom Pharmaceuticals, Inc. | 12 | $225 |
| Lilly USA, LLC | 7 | $198 |
| Merit Medical Systems Inc | 1 | $104 |
| QOL Medical, LLC | 3 | $89 |
Products named: REZDIFFRA, TREMFYA, IQIRVO, RINVOQ, ENTYVIO, VOQUEZNA, SKYRIZI, OMVOH.
Industry payments across AZ — which companies pay providers there.
